Sherlock Biosciences, IDT collaborate to manufacture CRISPR-based SARS-CoV-2 testing kits
Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide
Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide
Certification affirms commitment to providing the highest standards of quality and customer service
LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients
Highly specific prototype test detects the virus spike protein at clinically relevant concentrations
The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications
Our expert webinar series aims to help you get the most from your drug discovery research
The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19
This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic
Hybrid nanocapsules from renewable material hope to help cut carbon emissions
Deal enables a wider suite of pre-clinical testing services in oncology
New kits support analysis of all organs and species on fresh/fixed frozen and FFPE samples
The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients